Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Hogan

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Transplantation and Cellular Therapy|May 18, 2026
Dynamic-EASIX DRI model: a novel tool for predicting outcomes after allogeneic hematopoietic cell transplantationAnmol Baranwal, Rabee Kassis, Khalil Hassan, et al.
Annals of Hematology|January 3, 2024
Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipientsKiyan Heybati, Domenic Ochal, William Hogan, et al.
Haematologica|June 30, 2022
Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemiaNaseema Gangat, Isla Johnson, Kristen McCullough, et al.
Transplantation and Cellular Therapy|June 21, 2021
The Efficacy and Safety of Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma Patients Who Are Poor Responders to Induction: The Mayo Clinic ExperienceIuliana Vaxman, Eli Muchtar, Eapen Jacob, et al.
Leukemia & Lymphoma|May 13, 2022
Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantationMorie A Gertz, Rahma Warsame, Eli Muchtar, et al.
Cancer|October 20, 2011
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myelomaShaji K Kumar, Martha Q Lacy, Angela Dispenzieri, et al.
American Journal of Hematology|March 16, 2022
Real-world experience with luspatercept and predictors of response in myelodysplastic syndromes with ring sideroblastsFaiqa Farrukh, Deandra Chetram, Aref Al-Kali, et al.
American Journal of Hematology|August 4, 2018
The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDSOmar Alkharabsheh, Aref Al-Kali, Salwa Saadeh, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|May 3, 2021
Developing and Validating a Computable Phenotype for the Identification of Transgender and Gender Nonconforming Individuals and SubgroupsYi Guo, Xing He, Tianchen Lyu, et al.
European Journal of Haematology|June 8, 2012
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantationJonathan S Bleeker, Morie A Gertz, Patricia A Pellikka, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Transplantation and Cellular Therapy|May 18, 2026
Dynamic-EASIX DRI model: a novel tool for predicting outcomes after allogeneic hematopoietic cell transplantationAnmol Baranwal, Rabee Kassis, Khalil Hassan, et al.
Annals of Hematology|January 3, 2024
Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipientsKiyan Heybati, Domenic Ochal, William Hogan, et al.
Haematologica|June 30, 2022
Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemiaNaseema Gangat, Isla Johnson, Kristen McCullough, et al.
Transplantation and Cellular Therapy|June 21, 2021
The Efficacy and Safety of Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma Patients Who Are Poor Responders to Induction: The Mayo Clinic ExperienceIuliana Vaxman, Eli Muchtar, Eapen Jacob, et al.
Leukemia & Lymphoma|May 13, 2022
Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantationMorie A Gertz, Rahma Warsame, Eli Muchtar, et al.
Cancer|October 20, 2011
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myelomaShaji K Kumar, Martha Q Lacy, Angela Dispenzieri, et al.
American Journal of Hematology|March 16, 2022
Real-world experience with luspatercept and predictors of response in myelodysplastic syndromes with ring sideroblastsFaiqa Farrukh, Deandra Chetram, Aref Al-Kali, et al.
American Journal of Hematology|August 4, 2018
The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDSOmar Alkharabsheh, Aref Al-Kali, Salwa Saadeh, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|May 3, 2021
Developing and Validating a Computable Phenotype for the Identification of Transgender and Gender Nonconforming Individuals and SubgroupsYi Guo, Xing He, Tianchen Lyu, et al.
European Journal of Haematology|June 8, 2012
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantationJonathan S Bleeker, Morie A Gertz, Patricia A Pellikka, et al.
Pageof 11